TY - JOUR
T1 - White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy
AU - Su, Tanja
AU - Wit, Ferdinand W.N.M.
AU - Caan, Matthan W.A.
AU - Schouten, Judith
AU - Prins, Maria
AU - Geurtsen, Gert J.
AU - Cole, James H.
AU - Sharp, David J.
AU - Richard, Edo
AU - Reneman, Liesbeth
AU - Portegies, Peter
AU - Reiss, Peter
AU - Majoie, Charles B.
N1 - Funding Information: This work was supported by the Nuts-OHRA Foundation (grant no. 1003-026), Amsterdam, The Netherlands, as well as by The Netherlands Organization for Health Research and Development (ZonMW) together with AIDS Fonds (grant no 300020007 and 2009063). Additional unrestricted scientific grants were received from Gilead Sciences, ViiV Healthcare, Janssen Pharmaceutica N.V., Bristol-Myers Squibb, Boehringer Ingelheim, and Merck & Co. Publisher Copyright: © 2016 Wolters Kluwer Health, Inc.
PY - 2016/9/24
Y1 - 2016/9/24
N2 - Objectives: The objective of this study was to assess whether HIV-infected patients on long-term successful combination antiretroviral therapy (cART) have more extensive white matter hyperintensities (WMH) of presumed vascular origin compared with uninfected controls and whether these intensities are associated with cognitive impairment. Furthermore, we explored potential determinants of increased WMH load long-term suppressed HIV infection. Design: A cross-sectional comparison of WMH in an observational cohort. Methods: Clinical, cognitive, and MRI data were collected from 103 middle-aged, aviremic HIV-infected men on cART, and 70 HIV-uninfected, otherwise similar controls. In the MRI data, WMH load was quantified by automated approaches and qualitatively reviewed by an experienced neuro radiologist using the Fazekas scale. Results: HIV-infected men had an increased WMH load. Among HIV-infected patients, increased WMH load was independently associated with older age, higher DBP, higher D-dimer levels, and longer time spent with a CD4+ cell count below 500 cells/ml. HIV-associated cognitive deficits were associated with increased WMH load. Conclusions: WMH are more extensive and associated with cognitive deficits in middle-aged, aviremic cART-treated HIV-infected men. The extent of WMH load was associated with both cardiovascular risk factors and past immune deficiency. As cognitive impairment in these same patients is also associated with these risk factors, this may suggest that in the setting of HIV, WMH, and cognitive deficits share a common cause. This supports the importance of optimizing cardiovascular risk management, and early, effective treatment of HIV infection.
AB - Objectives: The objective of this study was to assess whether HIV-infected patients on long-term successful combination antiretroviral therapy (cART) have more extensive white matter hyperintensities (WMH) of presumed vascular origin compared with uninfected controls and whether these intensities are associated with cognitive impairment. Furthermore, we explored potential determinants of increased WMH load long-term suppressed HIV infection. Design: A cross-sectional comparison of WMH in an observational cohort. Methods: Clinical, cognitive, and MRI data were collected from 103 middle-aged, aviremic HIV-infected men on cART, and 70 HIV-uninfected, otherwise similar controls. In the MRI data, WMH load was quantified by automated approaches and qualitatively reviewed by an experienced neuro radiologist using the Fazekas scale. Results: HIV-infected men had an increased WMH load. Among HIV-infected patients, increased WMH load was independently associated with older age, higher DBP, higher D-dimer levels, and longer time spent with a CD4+ cell count below 500 cells/ml. HIV-associated cognitive deficits were associated with increased WMH load. Conclusions: WMH are more extensive and associated with cognitive deficits in middle-aged, aviremic cART-treated HIV-infected men. The extent of WMH load was associated with both cardiovascular risk factors and past immune deficiency. As cognitive impairment in these same patients is also associated with these risk factors, this may suggest that in the setting of HIV, WMH, and cognitive deficits share a common cause. This supports the importance of optimizing cardiovascular risk management, and early, effective treatment of HIV infection.
KW - HIV-1-infection
KW - HIV-associated cognitive impairment
KW - aging
KW - antiretroviral therapy
KW - cerebral small vessel disease
KW - white matter hyperintensities
UR - http://www.scopus.com/inward/record.url?scp=84965064167&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/QAD.0000000000001133
DO - https://doi.org/10.1097/QAD.0000000000001133
M3 - Article
C2 - 27149087
SN - 0269-9370
VL - 30
SP - 2329
EP - 2339
JO - AIDS
JF - AIDS
IS - 15
ER -